Description

Michael Toce, MD, MS, FACMT

Associate Physician in Pediatrics, Division of Emergency Medicine and Medical Toxicology

Assistant Professor of Pediatrics, Harvard Medical School

 

In this presentation, Dr. Michael Toce explains the clinical presentation and pathophysiology of cannabis hyperemesis syndrome (CHS). Dr. Toce also discusses the epidemiology of CHS and how it is changing based on shifts in cannabis legalization. Finally he outlines multiple treatment approaches for adolescents with CHS. This presentation was recorded at the 11th Annual Pediatric and Neonatal Critical Care Transport Team Conference on May 9, 2026.

Learning Objectives: 

At the conclusion of this educational program, learners will be able to:

1. Recognize the symptoms and pathophysiology of CHS among adolescents
2. Initiate appropriate treatment of adolescents with CHS

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurse

Boston Children’s Hospital designates this activity for 0.75 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity. 

Physician

Boston Children’s Hospital designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in this activity.

Disclosure Policy 
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients: